Phase II Trial of Taxol, an Active Drug in the Treatment of Metastatic Breast Cancer

Clicks: 2
ID: 306726
1991
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #236 of 333 articles by views in JNCI Journal of the National Cancer Institute

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 333 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Journal Article Phase II Trial of Taxol, an Active Drug in the Treatment of Metastatic Breast Cancer Get access Frankie Ann Holmes, Frankie Ann Holmes * Section of Breast Medical Oncology, Department of Medical Oncology, The University of Texas M. D. Anderson Cancer CenterHouston, Tex * Frankie Ann Holmes, M.D., The University of Texas M. D. Anderson Cancer Center-Box 95, 1515 Holcombe Blvd., Houston TX 77030. Search for other works by this author on: Oxford Academic PubMed Google Scholar Ronald S. Walters, Ronald S. Walters Section of Breast Medical Oncology, Department of Medical Oncology, The University of Texas M. D. Anderson Cancer CenterHouston, Tex Search for other works by this author on: Oxford Academic PubMed Google Scholar Richard L. Theriault, Richard L. Theriault Section of Breast Medical Oncology, Department of Medical Oncology, The University of Texas M. D. Anderson Cancer CenterHouston, Tex Search for other works by this author on: Oxford Academic PubMed Google Scholar Aman U. Buzdar, Aman U. Buzdar Section of Breast Medical Oncology, Department of Medical Oncology, The University of Texas M. D. Anderson Cancer CenterHouston, Tex Search for other works by this author on: Oxford Academic PubMed Google Scholar Debra K. Frye, Debra K. Frye Section of Breast Medical Oncology, Department of Medical Oncology, The University of Texas M. D. Anderson Cancer CenterHouston, Tex Search for other works by this author on: Oxford Academic PubMed Google Scholar Gabriel N. Hortobagyi, Gabriel N. Hortobagyi Section of Breast Medical Oncology, Department of Medical Oncology, The University of Texas M. D. Anderson Cancer CenterHouston, Tex Search for other works by this author on: Oxford Academic PubMed Google Scholar Arthur D. Forman, Arthur D. Forman Division of Medicine, Department of Neuro Oncology, The University of Texas M. D. Anderson Cancer Center Search for other works by this author on: Oxford Academic PubMed Google Scholar Lesley K. Newton, Lesley K. Newton Division of Medicine, Department of Neuro Oncology, The University of Texas M. D. Anderson Cancer Center Search for other works by this author on: Oxford Academic PubMed Google Scholar Martin N. Raber Martin N. Raber Clinical Trials Administration, Department of Medical Oncology, The University of Texas M. D. Anderson Cancer Center Search for other works by this author on: Oxford Academic PubMed Google Scholar JNCI: Journal of the National Cancer Institute, Volume 83, Issue 24, 18 December 1991, Pages 1797–1805, https://doi.org/10.1093/jnci/83.24.1797-a Published: 18 December 1991 Article history Received: 23 July 1991 Revision received: 03 October 1991 Accepted: 04 October 1991 Published: 18 December 1991
Reference Key
openalex_W4255152173 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Frankie A. Holmes, R S Walters, R. Theriault, A. U. Buzdar, D. Frye, G. N. Hortobágyi, A. D. Forman, L. K. Newton, Martin N. Raber
Journal JNCI Journal of the National Cancer Institute
Year 1991
DOI
10.1093/jnci/83.24.1797-a
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.